Chemical formula: C₁₈H₃₄N₂O₆S Molecular mass: 406.54 g/mol PubChem compound: 3000540
Lincomycin is an antibiotic produced by fermentation of Streptomyces lincolnensis. Lincomycin inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J01FF02 | Lincomycin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| LINCOCIN Solution for injection | Pharmaceutical Benefits Scheme (AU) | MPI, EU: SmPC |
Lincomycin is an active ingredient of these brands:
Australia (AU)
Brazil (BR)
Cyprus (CY)Hong Kong (HK)
Japan (JP)
Lithuania (LT)
Mexico (MX)
Nigeria (NG)
Poland (PL)
Singapore (SG)
Spain (ES)
Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
